Billing and Coding: MolDX: Genetic Testing for Hereditary Thrombophilia
National · Effective Oct 12, 2026
4 active Medicare policies list Z82.49, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
National · Effective Oct 12, 2026
5 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of Z82.49 |
|---|---|---|
| Genetic Testing | Feb 27, 2024 | Covered |
| Homocysteine Testing | Oct 26, 2023 | Covered |
| Policy | Effective | Status of Z82.49 |
|---|---|---|
| Concert Genetic Testing: Cardiovascular | Not recorded | Referenced |
| Concert Genetic Testing: Toxicology and Pharmacogenetics Version B | Not recorded | Referenced |
| Policy | Effective | Status of Z82.49 |
|---|---|---|
| Transthoracic Echocardiography in Adults | Sep 15, 2026 | Covered |